2023 AHA Update on Management Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning
EMDocs
NOVEMBER 6, 2023
Because venoarterial extracorporeal membrane oxygenation implementation takes time, the process should be started early in patients who are not responding well to other therapies. Flumazenil administration is associated with harm in patients who are at increased risk for seizures or dysrhythmias. COR No Benefit, LOE C-EO.
Let's personalize your content